These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31490845)

  • 1. Genomics and breast cancer screening.
    Tyler AL
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):485-487. PubMed ID: 31490845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards population-based genetic risk prediction for ovarian cancer.
    Rahman B; Side L; Gibbon S; Meisel SF; Fraser L; Gessler S; Wardle J; Lanceley A
    BJOG; 2017 May; 124(6):855-858. PubMed ID: 28217902
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
    Frost AS; Toaff M; Biagi T; Stark E; McHenry A; Kaltman R
    Obstet Gynecol; 2018 Jun; 131(6):1103-1110. PubMed ID: 29742654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
    Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
    Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V; ; Cilotti A; Di Maggio C; Fausto A; Preda L; Zuiani C; Contegiacomo A; Orlacchio A; Calabrese M; Bonomo L; Di Cesare E; Tonutti M; Panizza P; Del Maschio A
    Radiology; 2007 Mar; 242(3):698-715. PubMed ID: 17244718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer.
    Matulonis UA; Sood AK; Fallowfield L; Howitt BE; Sehouli J; Karlan BY
    Nat Rev Dis Primers; 2016 Aug; 2():16061. PubMed ID: 27558151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
    Hull LE; Haas JS; Simon SR
    Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
    Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UK breast screening program - what you need to know.
    Godley KC; Gladwell C; Murray PJ; Denton E
    Climacteric; 2017 Aug; 20(4):313-320. PubMed ID: 28661704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
    Heisey R; Carroll JC
    Can Fam Physician; 2016 Oct; 62(10):799-803. PubMed ID: 27737975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underuse of BRCA testing in patients with breast and ovarian cancer.
    Wright JD; Chen L; Tergas AI; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2016 Jun; 214(6):761-3. PubMed ID: 26875946
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening MRI in Women With a Personal History of Breast Cancer.
    Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
    Eccleston A; Bentley A; Dyer M; Strydom A; Vereecken W; George A; Rahman N
    Value Health; 2017 Apr; 20(4):567-576. PubMed ID: 28407998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Genetic Testing: What the Breast Surgeon Needs to Know.
    Plichta JK; Sebastian ML; Smith LA; Menendez CS; Johnson AT; Bays SM; Euhus DM; Clifford EJ; Jalali M; Kurtzman SH; Taylor WA; Hughes KS
    Ann Surg Oncol; 2019 Jul; 26(7):2184-2190. PubMed ID: 30941656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
    Sud A; Wham D; Catalano M; Guda NM
    Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US panel rejects routine use of BRCA cancer screening in women.
    McCarthy M
    BMJ; 2013 Apr; 346():f2160. PubMed ID: 23558348
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer].
    Jonas S; Wild C; Schamberger C
    Z Arztl Fortbild Qualitatssich; 2003 Feb; 97(1):67-71. PubMed ID: 12669692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing in women with breast cancer: implications for treatment.
    Paterson R; Phillips KA
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):991-1002. PubMed ID: 28853307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.